Literature DB >> 18817870

Prevention of calcineurin inhibitor nephrotoxicity in renal transplantation.

A Jacquet1, H Francois, C Frangie, L Ahmad, B Charpentier, A Durrbach.   

Abstract

Calcineurin inhibitors (CNI) cyclosporine (Csa) and tacrolimus (Tac) are now first intention immunosuppressive drugs in renal transplantation. However, although these treatments are effective for preventing allograft rejection, they are nephrotoxic: they can cause chronic renal dysfunction and degradation of renal graft function [Nankivell BJ, et al. The natural history of chronic allograft nephropathy. N Engl J Med. 2003 Dec 11;349(24):2326-33]. In view of these undesirable effects, several strategies have been developed to minimize or even avoid their use. These strategies are reviewed and discussed in this paper.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18817870     DOI: 10.1016/j.trim.2008.09.002

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  5 in total

Review 1.  Profile of belatacept and its potential role in prevention of graft rejection following renal transplantation.

Authors:  Gaurav Gupta; Karl L Womer
Journal:  Drug Des Devel Ther       Date:  2010-12-01       Impact factor: 4.162

Review 2.  Belatacept As an Alternative to Calcineurin Inhibitors in Patients with Solid Organ Transplants.

Authors:  Dhiren Kumar; Spencer LeCorchick; Gaurav Gupta
Journal:  Front Med (Lausanne)       Date:  2017-05-19

3.  Mitigation of Tacrolimus-Associated Nephrotoxicity by PLGA Nanoparticulate Delivery Following Multiple Dosing to Mice while Maintaining its Immunosuppressive Activity.

Authors:  Aws Alshamsan; Ziyad Binkhathlan; Mohd Abul Kalam; Wajhul Qamar; Hala Kfouri; Mohammed Alghonaim; Afsaneh Lavasanifar
Journal:  Sci Rep       Date:  2020-04-21       Impact factor: 4.379

4.  FK506 and Lactobacillus acidophilus ameliorate acute graft-versus-host disease by modulating the T helper 17/regulatory T-cell balance.

Authors:  Jin-Ah Beak; Min-Jung Park; Se-Young Kim; JooYeon Jhun; Jin Seok Woo; Jeong Won Choi; Hyun Sik Na; Soon Kyu Lee; Jong Young Choi; Mi-La Cho
Journal:  J Transl Med       Date:  2022-02-25       Impact factor: 5.531

5.  Tacrolimus Modulates TGF-β Signaling to Induce Epithelial-Mesenchymal Transition in Human Renal Proximal Tubule Epithelial Cells.

Authors:  Jason Bennett; Hilary Cassidy; Craig Slattery; Michael P Ryan; Tara McMorrow
Journal:  J Clin Med       Date:  2016-04-26       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.